A Comprehensive, Strong Response
MAPS submitted a lengthy written response to the WIRB letter, along with 14 letters of information and support from MDMA scientists around the world. MAPS’ letter addressed every point raised in …
A Glimmer of Hope. Rick Doblin Speaks with James Baldwin
Rick Doblin speaks with James Baldwin, Ph.D., Executive Director of the WIRB. Dr. Baldwin apologized for the tone of the WIRB letter and seemed to view favorably MAPS’ arguments. He was informed …
Outrageous News
Dr. George Ricaurte publishes an article in Science reporting on primate data that he claims suggests that even one night’s recreational use of Ecstasy can lead to Parkinson’s. This government-funded …
John Mendelson, M.D., Comments on MDMA Study Proposal
John Mendelson, M.D., Associate Professor at University California San Francisco, commented on Michael Mithoefer, M.D.s proposed MDMA study. Mendelson states that the risk of heart valve changes after …
MDMA Research Update: September 2002 – Terrible News: The Western IRB Approval Withdrawn
The Western IRB, which approved the MDMA/PTSD protocol on July 10, informed us by letter that approval was withdrawn. The revocation was based on secondhand reports of conversations (not on data!) that …
We received word that the Institutional Review Board (IRB) had approved MAPS MDMA/PTSD study
On July 10, we received word that the Institutional Review Board (IRB) had approved MAPS’ MDMA/PTSD study! We can now definitely say that the US study will take place. Dr. Michael Mithoefer still …
FY 2002 Financial Report
The basic balance sheet information for FY 2001-2002 is presented below. MAPS IRS Form 990 for 2002 is available in PDF format.MAPS total income for FY 2001-2002 was $775,945.A chart presenting comparative …
MDMA/PTSD protocol submitted to the Western Institutional Review Board
MDMA/PTSD protocol submitted to the Western Institutional Review Board (WIRB). Review expected to take 3-5 weeks.
FDA gives final approval to conduct the treatment sessions
FDA gives final approval to conduct the treatment sessions in Dr. Michael Mithoefer’s office, with a “crash cart” and an Emergency Room doctor and nurse in the next room in case they …
Conference call with Dr. Mithoefer, Rick Doblin and FDA officials
Conference call with Dr. Mithoefer, Rick Doblin and FDA officials, in which we come to tentative agreement to conduct the study in Dr. Mithoefer’s office, as long as we hire both an ER doctor and …
FDA Rejects Our Request
FDA rejects our request, primarily saying that they would like a larger emergency response team.
Follow-up study of Bastiaans LSD therapy
Investigators: Nicole Maalste, Hans Ossebaard Utrecht, Netherlands Contact: Sponsor: MAPS, Promind Foundation Retrospective survey study with former clients who were treated with drug therapy by Dr. Jan …
